Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease

Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease

Parkinson’s disease (PD) is a complex neurodegenerative disease characterized by the progressive loss of dopaminergic neurons in the substantia nigra and the widespread accumulation of alpha-synuclein (αSyn) protein aggregates. αSyn aggregation disrupts critical cellular processes, including synapti...

Full description

Bibliographic Details
Main Authors:	Kamil Saramowicz, Natalia Siwecka, Grzegorz Galita, Aleksandra Kucharska-Lusina, Wioletta Rozpędek-Kamińska, Ireneusz Majsterek
Format:	Article
Language:	English
Published:	MDPI AG 2023-12-01
Series:	International Journal of Molecular Sciences
Subjects:	Parkinson’s disease α-synuclein neurodegeneration Lewy bodies aggregation neurons
Online Access:	https://www.mdpi.com/1422-0067/25/1/360

Similar Items

Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy
by: Natalia Siwecka, et al.
Published: (2023-07-01)

Parkinson’s Disease: Exploring Different Animal Model Systems
by: Engila Khan, et al.
Published: (2023-05-01)

β-Synuclein: An Enigmatic Protein with Diverse Functionality
by: Junna Hayashi, et al.
Published: (2022-01-01)

<i>GBA1</i> Gene Mutations in α-Synucleinopathies—Molecular Mechanisms Underlying Pathology and Their Clinical Significance
by: Zuzanna Granek, et al.
Published: (2023-01-01)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
by: Tian-Sin Fan, et al.
Published: (2021-11-01)

Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
by: Hiroaki Sekiya, et al.
Published: (2022-09-01)

New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
by: Guoxin Zhang, et al.
Published: (2018-11-01)

Evaluation of the LDN-0060609 PERK Inhibitor as a Selective Treatment for Primary Open-Angle Glaucoma: An In Vitro Study on Human Retinal Astrocytes
by: Wioletta Rozpędek-Kamińska, et al.
Published: (2024-01-01)

Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders
by: Nelson de Oliveira Manzanza, et al.
Published: (2021-06-01)

Patient-Derived Induced Pluripotent Stem Cells and Organoids for Modeling Alpha Synuclein Propagation in Parkinson's Disease
by: Yong Hui Koh, et al.
Published: (2018-11-01)

Molecular Mechanisms Underlying NMDARs Dysfunction and Their Role in ADHD Pathogenesis
by: Justyna Kuś, et al.
Published: (2023-08-01)

Pyrroloquinoline quinone influences intracellular alpha-synuclein aggregates
by: Elizabeth Mountford, et al.
Published: (2023-01-01)

The Prion-Like Spreading of Alpha-Synuclein in Parkinson’s Disease: Update on Models and Hypotheses
by: Asad Jan, et al.
Published: (2021-08-01)

Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease
by: Scarlet eGallegos, et al.
Published: (2015-03-01)

Temporal Evolution of Inflammation and Neurodegeneration With Alpha-Synuclein Propagation in Parkinson's Disease Mouse Model
by: Thuy Thi Lai, et al.
Published: (2021-10-01)

Alpha-synuclein oligomers - neurotoxic molecules in Parkinson’s disease and other Lewy body disorders
by: Martin Ingelsson
Published: (2016-09-01)

Pathological Pathways and Alpha-Synuclein in Parkinson's Disease: A View from the Periphery
by: Milo Jarno Basellini, et al.
Published: (2023-02-01)

Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies
by: David J. Koss, et al.
Published: (2022-07-01)

Pathological Functions of LRRK2 in Parkinson’s Disease
by: Ga Ram Jeong, et al.
Published: (2020-11-01)

A Matrigel-based 3D construct of SH-SY5Y cells models the α-synuclein pathologies of Parkinson's disease
by: Zhao-Feng Li, et al.
Published: (2022-03-01)

Alpha Synuclein: Neurodegeneration and Inflammation
by: Gianluigi Forloni
Published: (2023-03-01)

Alpha-Synuclein Physiology and Pathology: A Perspective on Cellular Structures and Organelles
by: Luis D. Bernal-Conde, et al.
Published: (2020-01-01)

The Close Encounter Between Alpha-Synuclein and Mitochondria
by: Mattia Vicario, et al.
Published: (2018-06-01)

Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson’s disease and dementia with Lewy bodies
by: Connor Bargar, et al.
Published: (2021-04-01)

Effects of α-synuclein on axonal transport
by: Laura A. Volpicelli-Daley
Published: (2017-09-01)

Alpha-synuclein aggresomes inhibit ciliogenesis and multiple functions of the centrosome
by: Anila Iqbal, et al.
Published: (2020-10-01)

Accumulation of aggregated alpha-synuclein in neural tissue structures in neurodegenerative diseases
by: V. N. Salkov, et al.
Published: (2024-01-01)

A method of purifying alpha-synuclein in E. coli without chromatography
by: Sumaer Kamboj, et al.
Published: (2021-01-01)

Found in Translation: The Utility of <i>C. elegans</i> Alpha-Synuclein Models of Parkinson’s Disease
by: Anthony L. Gaeta, et al.
Published: (2019-03-01)

Are Therapies That Target α-Synuclein Effective at Halting Parkinson’s Disease Progression? A Systematic Review
by: Abbie T. Rodger, et al.
Published: (2023-07-01)

Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro
by: Janett Köppen, et al.
Published: (2020-01-01)

Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders
by: Rachel M. Wise, et al.
Published: (2022-12-01)

Mutation of Tyrosine Sites in the Human Alpha-Synuclein Gene Induces Neurotoxicity in Transgenic Mice with Soluble Alpha-Synuclein Oligomer Formation
by: Louise Berkhoudt Lassen, et al.
Published: (2022-11-01)

Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson’s Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology
by: Xiaojun Diao, et al.
Published: (2021-09-01)

The Role of Alpha-Synuclein Deposits in Parkinson’s Disease: A Focus on the Human Retina
by: Mariachiara Di Pippo, et al.
Published: (2023-02-01)

Editorial: The Protein Alpha-Synuclein: Its Normal Role (in Neurons) and Its Role in Disease
by: Ruth G. Perez
Published: (2020-02-01)

Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration
by: Xinhe Wang, et al.
Published: (2019-03-01)

Native α-Synuclein, 3-Nitrotyrosine Proteins, and Patterns of Nitro-α-Synuclein-Immunoreactive Inclusions in Saliva and Submandibulary Gland in Parkinson’s Disease
by: Emilio Fernández-Espejo, et al.
Published: (2021-05-01)

Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF
by: Walter A. Boiten, et al.
Published: (2020-12-01)

Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy?
by: Francesco De Nuccio, et al.
Published: (2023-02-01)